Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia
- PMID: 28163027
- PMCID: PMC5352525
- DOI: 10.1016/j.japh.2016.12.070
Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia
Abstract
Objectives: The objective of this study is to assess West Virginia pharmacists' stocking and dispensing practices of opioid-related medications and to identify the educational needs relating to providing naloxone in community pharmacies.
Design: A cross-sectional, anonymous, 49-item survey was created and validated to assess the educational needs of West Virginia community pharmacists.
Setting: West Virginia.
Participants: The data collection instrument was administered to 266 pharmacists currently licensed in West Virginia at 6 continuing pharmacy education events throughout the state from March 1 to June 15, 2016.
Outcome measures: Pharmacists' educational needs were determined using the Extended Parallel Process Model, which has 4 main constructs: perceived severity, perceived susceptibility, response efficacy, and self-efficacy. Pharmacists' stocking and dispensing of opioids and related medications were also assessed.
Results: Pharmacists completed 157 surveys. They were mostly male (56.1%), full-time employees (67.5%), worked mostly in community pharmacies (69.4%), and had a mean age of 50.19 years (SD = 13.62). The newly adapted opioid perceived efficacy and perceived severity of opioid adverse events scales were tested for reliability and validity. Only 20.4% of the community pharmacists surveyed felt comfortable selling naloxone without a prescription. As for the other opioid-related medications, only 53.3% stocked buprenorphine and 74.8% stocked buprenorphine/naloxone.
Conclusions: As the most accessible health care providers, community pharmacists are acutely aware of how the opioid epidemic affects their communities. Some pharmacists in West Virginia are hesitant to stock and dispense opioids and opioid-dependence medications. Although this may decrease the flow of potentially abused drugs into the community, it may also restrict access to necessary therapy for patients with opioid use disorder. Furthermore, pharmacists in West Virginia are not yet comfortable stocking and dispensing naloxone. Tailored educational materials can help in controlling the pharmacists' fear and reinforce the benefits of over-the-counter naloxone use.
Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence.J Am Pharm Assoc (2003). 2005 Jan-Feb;45(1):23-32. doi: 10.1331/1544345052843200. J Am Pharm Assoc (2003). 2005. PMID: 15730114 Clinical Trial.
-
Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama.Int J Drug Policy. 2019 Dec;74:229-235. doi: 10.1016/j.drugpo.2019.09.021. Epub 2019 Nov 5. Int J Drug Policy. 2019. PMID: 31698165
-
Assessing pharmacists' readiness to dispense naloxone and counsel on responding to opioid overdoses.J Am Pharm Assoc (2003). 2019 Jul-Aug;59(4):550-554.e2. doi: 10.1016/j.japh.2019.04.012. Epub 2019 May 17. J Am Pharm Assoc (2003). 2019. PMID: 31109812
-
What is known about community pharmacy supply of naloxone? A scoping review.Int J Drug Policy. 2016 Jun;32:24-33. doi: 10.1016/j.drugpo.2016.02.006. Epub 2016 Feb 15. Int J Drug Policy. 2016. PMID: 26949189 Review.
-
Pharmacists' naloxone services beyond community pharmacy settings: A systematic review.Res Social Adm Pharm. 2023 Feb;19(2):243-265. doi: 10.1016/j.sapharm.2022.09.002. Epub 2022 Sep 15. Res Social Adm Pharm. 2023. PMID: 36156267 Review.
Cited by
-
Barriers to Buprenorphine Dispensing by Medicaid-Participating Community Retail Pharmacies.JAMA Health Forum. 2024 May 3;5(5):e241077. doi: 10.1001/jamahealthforum.2024.1077. JAMA Health Forum. 2024. PMID: 38758569 Free PMC article.
-
Protocol for the development of a consensus practice guideline To address clinical and regulatory barriers to buprenorphine dispensing in community pharmacy.Arch Public Health. 2024 Apr 25;82(1):58. doi: 10.1186/s13690-024-01287-4. Arch Public Health. 2024. PMID: 38664777 Free PMC article.
-
Naloxone Accessibility by Standing Order in North Carolina Community Pharmacies.J Am Pharm Assoc (2003). 2024 May-Jun;64(3):102021. doi: 10.1016/j.japh.2024.01.017. Epub 2024 Feb 1. J Am Pharm Assoc (2003). 2024. PMID: 38307248 Free PMC article.
-
Naloxone co-prescriptions for surgery patients prescribed opioids: A retrospective cohort study.Surg Pract Sci. 2023 Dec;15:100217. doi: 10.1016/j.sipas.2023.100217. Epub 2023 Sep 11. Surg Pract Sci. 2023. PMID: 38222465 Free PMC article.
-
Injection Drug Use Frequency Before and After Take-Home Naloxone Training.JAMA Netw Open. 2023 Aug 1;6(8):e2327319. doi: 10.1001/jamanetworkopen.2023.27319. JAMA Netw Open. 2023. PMID: 37540514 Free PMC article.
References
-
- Center for Behavioral Health Statistics and Quality Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. 2015 http://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR....
-
- Centers for Disease Control and Prevention Opioid Painkiller Prescribing. CDC Vital Signs 2014. 2016 http://www.cdc.gov/vitalsigns/opioid-prescribing/
-
- Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in Drug and Opioid Overdose Deaths - United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64(50-51):1378–1382. - PubMed
-
- Appalachain Regional Commission Counties in Appalachia. 2016 http://www.arc.gov/research/RegionalDataandResearch.asp, 2016.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials